Skip to content

Clinical trials

Cardiovascular Diseases trials in Brazil

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Cardiovascular Diseases Country / region: Brazil Clear all

151 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20022
20033
20051
20063
20072
20085
20096
20108
201110
201210
20134
20146
20157
20165
20178
201810
20199
20203
20219
20228
20239
202410
20258
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed75
Unknown status26
Recruiting18
Active, not recruiting14
Terminated13
Not yet recruiting2
Withdrawn2
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of Sao Paulo18
Novartis Pharmaceuticals9
Hospital de Clinicas de Porto Alegre8
Eli Lilly and Company5
Universidade Estadual Paulista Júlio de Mesquita Filho5
AstraZeneca4
Federal University of Health Science of Porto Alegre4
Hospital Israelita Albert Einstein4
University of Campinas, Brazil4
University of Sao Paulo General Hospital4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Cardiovascular Diseases151
Hypertension22
Coronary Artery Disease16
Stroke15
Atherosclerosis14
Heart Diseases12
Myocardial Infarction12
Coronary Disease10
Vascular Diseases9
Diabetes Mellitus, Type 28

Trials

Showing 26 to 50 of 151. Each trial links to its page on Pharma Observatory.

51 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.